It is consistent with NME4 mRNA levels in human breast tumor cell lines, which are high in hormone receptor-positive cell lines (favorable prognosis), but low in triple-negative cell lines (poor prognosis). The gene discussed is NR4A1; the disease is breast neoplasm.